MOH — authorised 28 August 1972
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: likely_approved
MOH authorised Efrane on 28 August 1972
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 28 August 1972.
BAXTER HLTHCARE holds the UAE marketing authorisation.